RecruitingNCT06334835

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood


Sponsor

IRCCS SYNLAB SDN

Enrollment

20 participants

Start Date

Apr 30, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Long non-coding RNAs (lncRNAs) are a class of biomarkers of crescent interest in the hematologic and oncologic field. They do not encode proteins and can alter gene expression by acting on different steps of regulation, including DNA methylation and chromatin structure. Recent data identified recurrent somatic alterations in genes involved in DNA methylation and post-translational histone modifications in T-ALL, suggesting that epigenetic homeostasis is critically required in restraining tumor development in the T-cell lineage. Further, recent studies showed that the expression levels of specific lncRNAs correlate with the prognosis of patients with Acute Lymphoblastic Leukemia of T-cells (T-ALL). The objectives of this research project are to identify T-ALL-specific lncRNAs to be used as new diagnostic and prognostic biomarkers of disease and to explore their role on chromatin reorganization and transcriptional regulation that may lead to the onset and progression of T-ALL.


Eligibility

Min Age: 1 YearMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether certain molecules in the blood (long non-coding RNAs, or lncRNAs) can serve as early diagnostic markers for T-cell acute lymphoblastic leukemia (T-ALL), a fast-moving blood cancer that mainly affects children and teens. The goal is to improve early detection. **You may be eligible if...** - You are between 1 and 18 years old - You have been diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) - Leukemia cells are present in your blood at the time of diagnosis **You may NOT be eligible if...** - You or your guardian refuses to participate - You do not fall within the 1–18 age range Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTlncRNA signature analyses

Evaluation of a signature of identified lncRNA in a cohort of childhood T-ALL patients in comparison with healthy subjects.


Locations(1)

Irccs Synlab Sdn

Naples, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06334835


Related Trials